Insiders · Profile

PERLMUTTER ROGER M

Exe V-P & Pres, MRL at Merck · EVP, Research & Development at Amgen. Filing since 2 Jun 2009. CIK 0001184228

Company

Date

Role

Action

Amount

Of holding

8 Nov 2018

Exe V-P & Pres, MRL

Sold, plan not stated

225,443

$16.97M

61.4%

2 Feb 2012

EVP, Research & Development

Sold, plan not stated

75,000

$5.24M

28.7%

2 Jun 2009

Exe VP, Research & Development

Sold, plan not stated

85,000

$4.34M

36.3%

3 decisions on file.